Podcast Highlights

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

By December 4, 2020April 1st, 2022No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

Current Understanding of the Pathophysiology, Etiology, Prevalence & Burden of AD

Dr. Peter Lio and Dr. Adam Friedman

 

In part 2 of this 5 part podcast homage to Atopic Dermatitis, JDD Podcast host Dr. Adam Friedman is joined by the dynamic dermatitis duo Dr. Anna De Benedetto, Associate Professor of Dermatology at the University of Florida, and Dr. Eric Simpson, Professor of Dermatology at the School of Medicine at Oregon Health & Science University, to dissect established and emerging pathophysiologic details of this dastardly dermatitis.

Dig in to determine best evidence based management practices to dampen the long standing burden of disease. Discover delightful discourse between three dedicated AD investigators/caregivers. Do listen, don’t scratch.

Listen Now

This podcast is supported by an independent medical education grant provided by Sanofi Genzyme & Regeneron Pharmaceuticals.

 

 

Learning Objectives:
Upon completion of this podcast, learners should be able to:
  • Summarize recent scientific understanding of the pathophysiology, etiology and prevalence of atopic dermatitis in patients of all age groups
  • Recognize the implications of long-term treatment options on effective patient outcomes.

You May Also Like

Scouting the Scalp: Practical and Case-Based Approaches to Managing Hair and Scalp Diseases

| Featured Articles, Featured Podcast, Hair, Podcast Highlights, The Latest | No Comments
Featured Podcast Managing alopecia is already anxiety provoking enough, but throw some  inflammatory scalp diseases into the mix...ok deep breaths...think of a happy place. So happy your brain brought you…

Treat to (Stay on) Target(ted Therapies)

| Featured Articles, Featured Podcast, Podcast Highlights, Skin Cancer, The Latest | No Comments
Featured Podcast Cancer has met its match with the rise of new targeted therapies. However with the expanding cancer busting armament comes with the baggage of new and emerging cutaneous…

State of the Acne Management Union: Stud or Dud?

| Acne, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Don't pop, rather pick a therapeutic strategy from the wide array of new….oh wait, nevermind.  The world of acne treatment R&D is unfortunately shrinking as payors pick away…

Leave a Reply